Watson Laboratories, a subsidiary of Watson Pharmaceuticals, has received FDA approval for its abbreviated new drug application (ANDA) of Trospium Chloride Extended-release Capsules. Watson anticipates beginning the shipment of the ...
Tags: FDA, Trospium Chloride Extended-release Capsules, pharmaceutical product
Allergan and Molecular Partners have expanded their existing relationship by entering into two separate agreements to discover, develop and commercialize proprietary therapeutic DARPin products to treat ophthalmic diseases. The first ...
BOTOX Cosmetic (onabotulinumtoxinA) Celebrates 10-Year Anniversary of U.S. Food and Drug Administration Approval. BOTOX Cosmetic is a prescription medicine that is injected into muscles and used to improve the look of moderate to severe ...
Tags: BOTOX Cosmetic, 10-year anniversary, FDA, frown lines, glabellar lines